Form 4: Maravai LifeSciences General Counsel Acquires Shares Through Employee Stock Purchase Plan

Kurt Oreshack, General Counsel of Maravai LifeSciences, acquired 366 shares of Class A Common Stock through the company's Employee Stock Purchase Plan.

Summary

• Kurt Oreshack, the General Counsel of Maravai LifeSciences Holdings, Inc., acquired 366 shares of Class A Common Stock on October 31, 2024.
• The shares were purchased at a price of $5.70 per share.
• This transaction was made through the company's 2020 Employee Stock Purchase Plan.
• The acquisition is exempt under Rule 16b-3.
• Following this transaction, Mr. Oreshack directly owns 224,056 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, indicating a positive but not extraordinary sentiment. The acquisition of shares by an executive through an employee plan is generally viewed as a positive sign of confidence in the company.

Positives

• The acquisition of shares by a company officer through the Employee Stock Purchase Plan can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine transaction related to employee stock purchase plans, which are common in publicly traded companies. It reflects an executive's participation in such a plan.

Comparison to Industry Standards

• Employee stock purchase plans are a common practice among publicly traded companies, particularly in the technology and life sciences sectors.
• The transaction is consistent with standard practices for executives acquiring shares through such plans.
• Similar transactions are regularly reported by executives at comparable companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates confidence from a company executive.

Key Dates

Keywords

Maravai LifeSciences, Employee Stock Purchase Plan, Class A Common Stock, insider trading, Form 4, equity, stock acquisition, Kurt Oreshack